Summit Global Investments’s Royalty Pharma RPRX Stock Holding History

Summit Global Investments’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-25,991	Closed	-$735K	–	622
2024 Q3	$735K	Buy	+25,991	New	+$720K	0.05%	294
2024 Q1	–	Sell	-8,915	Closed	-$250K	–	586
2023 Q4	$250K	Sell	8,915 -2,264	-20%	-$62.2K	0.02%	461
2023 Q3	$303K	Sell	11,179 -163,271	-94%	-$4.85M	0.02%	424
2023 Q2	$5.36M	Buy	174,450 +33,069	+23%	+$1.12M	0.36%	72
2023 Q1	$5.09M	Buy	141,381 +3,181	+2%	+$118K	0.39%	70
2022 Q4	$5.46M	Buy	138,200 +581	+0.4%	+$24.3K	0.46%	65
2022 Q3	$5.53M	Sell	137,619 -891	-0.6%	-$38.1K	0.51%	54
2022 Q2	$5.82M	Buy	138,510 +5,545	+4%	+$227K	0.51%	50
2022 Q1	$5.18M	Buy	+132,965	New	+$5.22M	0.38%	75

Other funds holding RPRX

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Adage Capital Partners

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Baillie Gifford & Co

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Viking Global Investors

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return